Crohns Targeted Therapy: Myth or Real Goal?
Klaus J. Schmidt(University Gastroenterology), Klaus Fellermann(Apple (Israel)), Carsten Jankowiak(University Hospital Schleswig-Holstein), Jürgen Büning(University Hospital Schleswig-Holstein), Hendrik Lehnert(University of Salzburg)
Cited by 15
Related Papers
Reduced Paneth cell α-defensins in ileal Crohn's disease
|Proceedings of the National Academy of Sciences|2005|969
NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression
|Gut|2004|798
A Chromosome 8 Gene-Cluster Polymorphism with Low Human Beta-Defensin 2 Gene Copy Number Predisposes to Crohn Disease of the Colon
|The American Journal of Human Genetics|2006|566
NF-κB- and AP-1-Mediated Induction of Human Beta Defensin-2 in Intestinal Epithelial Cells by<i>Escherichia coli</i>Nissle 1917: a Novel Effect of a Probiotic Bacterium
|Infection and Immunity|2004|469
The Predictive Value of Different Measures of Obesity for Incident Cardiovascular Events and Mortality
|The Journal of Clinical Endocrinology & Metabolism|2010|465